Page last updated: 2024-10-30

maprotiline and Central Nervous System Diseases

maprotiline has been researched along with Central Nervous System Diseases in 1 studies

Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
"Seizures were more common in the amoxapine (24."1.27Relative toxicity of cyclic antidepressants. ( Gorman, RL; Klein-Schwartz, W; Oderda, GM; Wedin, GP, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wedin, GP1
Oderda, GM1
Klein-Schwartz, W1
Gorman, RL1

Other Studies

1 other study available for maprotiline and Central Nervous System Diseases

ArticleYear
Relative toxicity of cyclic antidepressants.
    Annals of emergency medicine, 1986, Volume: 15, Issue:7

    Topics: Adolescent; Adult; Aged; Amoxapine; Anthracenes; Antidepressive Agents, Tricyclic; Arrhythmias, Card

1986